국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
azelastine hydrochloride, Quantity: 137 microgram/actuation (Equivalent: azelastine, Qty 125 microgram/actuation); fluticasone propionate, Quantity: 50 microgram/actuation
Arrotex Pharmaceuticals Pty Ltd
Azelastine hydrochloride,fluticasone propionate
Spray, nasal
Excipient Ingredients: benzalkonium chloride; purified water; polysorbate 80; glycerol; disodium edetate; phenethyl alcohol; microcrystalline cellulose; carmellose sodium
Nasal
120 metered sprays
(S4) Prescription Only Medicine
Symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.
Visual Identification: A white suspension in an amber glass bottle with a metering nasal pump and white actuator with translucent cap.; Container Type: Bottle, with integral pump - manual actuated; Container Material: Glass Type I Coloured; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Restricted flow insert
Licence status A
2017-08-22